<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-057391</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Membranes in acute renal failure</dc:title>
<dc:description xml:lang="en">When choosing the appropriate dialysis membrane in the acute setting, both biocompatibility    and permeability should be considered. The parameters used when selecting a    filter for acute dialysis are small solute removal, middle/large solute removal, and biocompatibility.    With respect to small solute removal, membrane pore characteristics    (pore size distribution and density) and surface area are important membrane-related    determinants.    Membrane characteristics define biocompatibility, although other factors, such as disinfectants    may influence. Unlike in chronic hemodialysis, in which leukopenia and    complement activation are well-accepted indicators of poor biocompatibility (i.e. bioincompatibility),    the markers of inflammation in critically ill patients with acute renal failure    are less clearly defined. In critical patients with acute renal failure activation of several    inflammatory pathways preclude clear evaluation of the independent contribution of    membrane biocompatibility. However, it has been demonstrated that in patients with    acute renal failure, the use of cuprophan membranes can lead to complement activation    and lipoxygenase stimulation.    Despite initial studies demonstrated lower mortality with the use of biocompatible    membranes in acute renal failure, subsequent studies casted doubts on these earlier findings.    Most studies were undepowered and had randomization problems. Current evidence    does not allow to recommend the unrestricted use of biocompatible membranes.    However, bioincompatible membranes (grade B) and unsubstituted cellulose membranes    (grade A) should be avoided.    With respect to permeability, each membrane has intrinsic permeability characteristic    that allow their classification according to their water and solute permeability. With respect    to water permeability, membranes are classified according the ultrafiltration coefficient    (CUF) expressed as mL/h/mmHg (ultrafiltered mL per hour per each mmHg of    transmembrane pressure). Low permeability membranes are those with a CUF lower    than 12 mL/h/mm Hg and high permeability membranes those with a CUF higher than    20 mL/h/mm Hg.    With respect to solute permeability, membranes should resemble the native kidney,    with a cut-off for albumin. Solute permeability is expressed by the sieving coefficient.    Currently, it is not possible to recommend permeability characteristics for dislyzer membranes    in the treatment of acute renal failure. However, it is plausible to recommend    medium-high permeability membranes (grade C). The decision will be influenced by    the dialysis modality in each particular patient</dc:description>
<dc:creator>Poch, E</dc:creator>
<dc:creator>Maduell, F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Las membranas de diálisis con las mejores propiedades biológicas deben ser biocompatibles,    capaces de excluir las impurezas del baño de diálisis y tener grandes    poros que permitan la eliminación de sustancias lo más parecido al riñón nativo    sano, con pérdida casi nula de albúmina o moléculas de mayor tamaño. Los dializadores que mejor se ajustan a estas características son los dializadores de alto flujo    o de alta permeabilidad. En la elección de la membrana de diálisis para el tratamiento    del FRA se deben tener en cuenta la biocompatibilidad y la permeabilidad a    pequeños solutos y a solutos de tamaño mediano-grande</dc:description>
<dc:source>Nefrologia;27(supl.3): 123-130, 2007.</dc:source>
<dc:identifier>ibc-057391</dc:identifier>
<dc:title xml:lang="es">Membranas en el fracaso renal agudo</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d29413^s22039</dc:subject>
<dc:subject>^d1696</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d8737</dc:subject>
<dc:subject>^d53982^s22067</dc:subject>
<dc:subject>^d10729</dc:subject>
<dc:subject>^d29407^s22039</dc:subject>
<dc:type>article</dc:type>
<dc:date>200700</dc:date>
</metadata>
</record>
</ibecs-document>
